You can access any of the podium or poster presentations’ abstracts by searching for it below. For the 2026 FIP world congress in Montreal, presentations and summaries from invited speakers are available below, while abstracts are published in the Pharmacy Education Journal (PEJ) here.
Export this Abstract | Print this Abstract |
Add to my preferred Abstracts list |
My preferred Abstracts list (0) |
Back to Search
Industry perspectives on regulating innovative medicines
- In: Symposium D1: New approaches of regulating innovative medicines on Monday, 22 May 2017, 16:40-17:15
- At: Stockholm (Sweden) (2017)
- Type: Presentation
- By: SCHEEREN, Joseph (Bayer Consumer Care AG, Regulatory Affairs Pharma & Consumer Health, Basel, Switzerland)
- Co-author(s): Joseph Scheeren: Regulatory Affairs Pharma & Consumer Health, Bayer Consumer Care AG, Basel, Switzerland
- Abstract:
In a globalizing pharmaceutical world with empowered patients the commitment for enabling early patient access to new innovative medicines is one of the major challenges for the industry and the regulators. Initiatives like ICH (International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use)
.. The access to the whole abstract and if available the presentation file is available to FIP members and to congress participants of that specific congress.
Please login
Last update 23 September 2026